Conference Details - Program

Bard Biopsy Systems, A Business Unit of Bard Peripheral Vascular, Inc. Bard is the world leader in biopsy innovations. Bard’s newest innovation, the Finesse™ Ultra Breast Biopsy System, is the only self-contained, vacuum-assisted, ultrasound-guided breast biopsy system with SIMS Technology—the ability to acquire multiple samples with a single probe insertion. With sampling cycle time just 10 seconds, the Finesse Ultra Breast Biopsy System acquires large, high-quality, contiguous tissue samples rapidly from a single insertion. Its ultrasharp cutting tip and optional piercing mode penetrates dense breast tissue and lesions accurately without displacing the lesion. The detachable integrated coaxial cannula can remain in the breast to maintain a track to the biopsy site to accurately place a breast tissue marker. The Finesse Ultra Breast Biopsy System provides compassionate control of the patient... more

Each participant will gain knowledge and hands-on experience with the following advanced technologies for state-of-the art diagnosis and treatment of breast disease:

• Image-guided breast biopsy using the Mammotome^® System under ultrasound guidance. Mammotome EX, used under ultrasound guidance, enables doctors to perform diagnostic sampling and remove imaged evidence in a single office procedure and can be performed with both 11G and 8G probes. MammoMARK™ Biopsy Site Identifiers offer reliable marking for confirmation with magnetic resonance, x-ray, or ultrasound imaging.
• Intraoperative Lymphatic Mapping and SLN Dissection for the staging and management of breast cancer, cutaneous melanoma, and other applications using Neoprobe^® Gamma Detection Systems.
• HARMONIC^® technology, which redefines the breast surgery and recovery process for patient and surgeon. Intraoperatively, it enhances precise dissection and increases surgical efficiency as an alternative... more

This workshop is designed for surgeons who are interested in expanding their practice and learning about new technologies for in-office procedures. Participants will learn about the recently released MammoSite^® Multi-Lumen 5-Day Radiation Therapy System and the Celero^® breast biopsy device. The workshop will include the 5-year ASBS MammoSite registry update and information on surgical techniques utilizing Celero and MammoSite under ultrasound guidance. Participants will also have a hands-on opportunity to work with these products and consult with a surgeon colleague who utilizes both MammoSite and Celero.

Paul S. Dale, MD • Surgeon, Ellis Fischel Cancer Center • Columbia, MO

This session will offer insights on the newest technology in stereotactic biopsy and its impact on patient-focused care along with associated benefits. Participants will have the opportunity to operate the ATEC^® breast biopsy system and the new Eviva device for stereotactic breast biopsy. This workshop also features stereotactic-guided breast biopsy on the MultiCare^® Platinum prone biopsy table.

Richard Fine, MD • Surgeon, Advanced Breast Care • Marietta, GA

Bard Biopsy Systems, A Business Unit of Bard Peripheral Vascular, Inc. Bard is the world leader in biopsy innovations. Bard’s newest innovation, the Finesse™ Ultra Breast Biopsy System, is the only self-contained, vacuum-assisted, ultrasound-guided breast biopsy system with SIMS Technology—the ability to acquire multiple samples with a single probe insertion. With sampling cycle time just 10 seconds, the Finesse Ultra Breast Biopsy System acquires large, high-quality, contiguous tissue samples rapidly from a single insertion. Its ultrasharp cutting tip and optional piercing mode penetrates dense breast tissue and lesions accurately without displacing the lesion. The detachable integrated coaxial cannula can remain in the breast to maintain a track to the biopsy site to accurately place a breast tissue marker. The Finesse Ultra Breast Biopsy System provides compassionate control of the patient... more

Each participant will gain knowledge and hands-on experience with the following advanced technologies for state-of-the art diagnosis and treatment of breast disease:

• Image-guided breast biopsy using the Mammotome^® System under ultrasound guidance. Mammotome EX, used under ultrasound guidance, enables doctors to perform diagnostic sampling and remove imaged evidence in a single office procedure and can be performed with both 11G and 8G probes. MammoMARK™ Biopsy Site Identifiers offer reliable marking for confirmation with magnetic resonance, x-ray, or ultrasound imaging.
• Intraoperative Lymphatic Mapping and SLN Dissection for the staging and management of breast cancer, cutaneous melanoma, and other applications using Neoprobe^® Gamma Detection Systems.
• HARMONIC^® technology, which redefines the breast surgery and recovery process for patient and surgeon. Intraoperatively, it enhances precise dissection and increases surgical efficiency as an alternative... more

This workshop is designed for surgeons who are interested in expanding their practice and learning about new technologies for in-office procedures. Participants will learn about the recently released MammoSite^® Multi-Lumen 5-Day Radiation Therapy System and the Celero^® breast biopsy device. The workshop will include the 5-year ASBS MammoSite registry update and information on surgical techniques utilizing Celero and MammoSite under ultrasound guidance. Participants will also have a hands-on opportunity to work with these products and consult with a surgeon colleague who utilizes both MammoSite and Celero.

Paul S. Dale, MD • Surgeon, Ellis Fischel Cancer Center • Columbia, MO

This session will offer insights on the newest technology in stereotactic biopsy and its impact on patient-focused care along with associated benefits. Participants will have the opportunity to operate the ATEC^® breast biopsy system and the new Eviva device for stereotactic breast biopsy. This workshop also features stereotactic-guided breast biopsy on the MultiCare^® Platinum prone biopsy table.

Richard Fine, MD • Surgeon, Advanced Breast Care • Marietta, GA